Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty (CME)

Transfusion

Volumn 51, Issue 1, 2011, Pages 118-124

  Na, Hyo Seok ^a,b,c   Shin, Soon Young ^a,b,c   Hwang, Jin Young ^a,b,c   Jeon, Young Tae ^a,b,c   Kim, Chong Soo ^a,b,c   Do, Sang Hwan ^a,b,c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; FENTANYL; FERRIC HYDROXIDE SUCROSE; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN BETA; RECORMON BETA; TRANSFERRIN; UNCLASSIFIED DRUG; VENOFERRUM;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD; BLOOD SAMPLING; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOVOLEMIA; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON DEFICIENCY ANEMIA; BETA; IRON THERAPY; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OXYGEN SATURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TOTAL KNEE REPLACEMENT; TRANSFERRIN BLOOD LEVEL; TREATMENT OUTCOME;

AGED; ANEMIA, IRON-DEFICIENCY; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; HUMANS; IRON; POSTOPERATIVE HEMORRHAGE;

EID: 78651377892     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02783.x     Document Type: Article

References (34)

1. Senthil Kumar G, Von Arx OA, Pozo JL,. Rate of blood loss over 48 hours following total knee replacement. Knee 2005; 12: 307-9.
2. Sehat KR, Evans R, Newman JH,. How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 2000; 7: 151-5.
3. Conlon NP, Bale EP, Herbison GP, McCarroll M,. Postoperative anemia and quality of life after primary hip arthroplasty in patients over 65 years old. Anesth Analg 2008; 106: 1056-61.
4. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL,; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
5. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB,. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10.
6. Gonzalez-Porras JR, Colado E, Conde MP, Lopez T, Nieto MJ, Corral M,. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Transfus Med 2009; 19: 35-42.
7. Cuenca J, Garcia-Erce JA, Martinez F, Pérez-Serrano L, Herrera A, Muñoz M,. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006; 46: 1112-9.
8. Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, Dematteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M,. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg 2008; 248: 360-9.
9. Zacharopoulos A, Apostolopoulos A, Kyriakidis A,. The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. Int Orthop 2007; 31: 303-8.
10. Mircescu G, Garneata L, Capusa C, Ursea N,. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant 2006; 21: 120-4.
11. Cheer SM, Wagstaff AJ,. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer. Drugs 2004; 64: 323-46.
12. Goodnough LT,. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy. Nephrol Dial Transplant 2002; 17 Suppl 5: 14-8.
13. Monk TG,. Preoperative recombinant human erythropoietin in anemic surgical patients. Crit Care 2004; 8 Suppl 2: S45-8.
14. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM,. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006; 53: 11-9.
15. Kettelhack C, Hones C, Messinger D, Schlag PM,. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998; 85: 63-7.
16. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY,. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000; 133: 845-54.
17. Wish JB,. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006; 1 Suppl 1: S4-8.
18. Bermejo F, Garcia-Lopez S,. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol 2009; 15: 4638-43.
19. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17.
20. Liu TK, Chen SH,. Simultaneous bilateral total knee arthroplasty in a single procedure. Int Orthop 1998; 22: 390-3.
21. Bould M, Freeman BJ, Pullyblank A, Newman JH,. Blood loss in sequential bilateral total knee arthroplasty. J Arthroplasty 1998; 13: 77-9.
22. Madjdpour C, Heindl V, Spahn DR,. Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol 2006; 72: 283-98.
23. Goodnough LT, Skikne B, Brugnara C,. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
24. Weisbach V, Skoda P, Rippel R, Lauer G, Glaser A, Zingsem J, Zimmermann R, Eckstein R,. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. Transfusion 1999; 39: 465-72.
25. Besarab A, Horl WH, Silverberg D,. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. Oncologist 2009; 14 Suppl 1: 22-33.
26. Crosby E,. Perioperative use of erythropoietin. Am J Ther 2002; 9: 371-6.
27. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, Brett S, Goldhill DR, Soni N,. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90: 105-12.
28. Coyne D,. Iron indices: what do they really mean? Kidney Int Suppl 2006; S4-8.
29. de Andrade JR, Frei D, Guilfoyle M,. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery. Orthopedics 1999; 22: s113-8.
30. Hu S, Zhang ZY, Hua YQ, Li J, Cai ZD,. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br 2009; 91: 935-42.
31. Vitale MG, Roye BD, Ruchelsman DE, Roye DP Jr,. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes. Spine J 2007; 7: 292-300.
32. Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C,. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006; 10: 1-210.
33. Coyle D, Lee KM, Fergusson DA, Laupacis A,. Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med 1999; 9: 21-30.
34. Green WS, Toy P, Bozic KJ,. Cost Minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplasty 2010; 25: 93-6.